Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will commit funding for research into glioblastoma brain tumours.

Research is crucial in tackling cancer, which is why the Department spends £1.5 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR), with cancer being the largest area of spend, at over £121.8 million in 2022/23. The NIHR spends more on cancer than any other disease group, reflecting its high priority.

In the five years between 2018/19 and 2022/23, the NIHR spent over £11.3 million on research projects focussed on brain tumours. In addition, our wider investments in NIHR research infrastructure, including facilities, services, and the research workforce, further allows us to leverage research funding from other donors and organisations. These investments are estimated to be £31.5 million, between 2018/19 and 2022/23, and have enabled 227 brain cancer research studies to take place in the same period.

Brain cancer remains one of the hardest to treat cancers in both adults and children and we urgently need more research to inform our efforts, which is why in September the NIHR announced new research funding opportunities for brain cancer research, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure the most promising research opportunities are made available to adult and child patients, and a new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation. Further information is available at the following link:

https://www.nihr.ac.uk/news/new-funding-opportunities-novel-brain-tumour-research-launched

We are committed to furthering our investment and support for high-quality brain tumour research, ensuring that the funding is used in the most meaningful and impactful way.